Phase 2

Prostate Cancer Clinical Trial

Recruiting
Recruiting
Recruiting
Recruiting
Estimated trial completion date

METANOVA Trial

The METANOVA Trial investigates treating oligometastatic prostate cancer with metastasis-directed radiotherapy (MDRT) in addition to standard systemic and prostate-directed therapy.

MDRT, using targeted radiation on all metastatic sites, aims to extend the time until cancer returns and potentially improve patient survival.

Join this Clinical trial

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Join the METANOVA Trial Clinical Trial

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.